These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32712639)

  • 1. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
    Tan CS; Yeoh SF; Long CM
    Ann Acad Med Singap; 2020 Jun; 49(6):398-400. PubMed ID: 32712639
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
    Delpino MV; Quarleri J
    Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
    [No Abstract]   [Full Text] [Related]  

  • 4. Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
    Peiró C; Moncada S
    Circulation; 2020 May; 141(21):1665-1666. PubMed ID: 32242749
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
    Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
    Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
    [No Abstract]   [Full Text] [Related]  

  • 6. Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infection.
    Soto M; diZerega G; Rodgers KE
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320972018. PubMed ID: 33169644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise as medicine for COVID-19: An ACE in the hole?
    Heffernan KS; Jae SY
    Med Hypotheses; 2020 Sep; 142():109835. PubMed ID: 32428811
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 challenging cell biology.
    Bullerdiek J
    Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
    [No Abstract]   [Full Text] [Related]  

  • 9. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
    Murray E; Tomaszewski M; Guzik TJ
    Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?
    Monje MHG; Martínez-Fernández R
    Mov Disord; 2020 Oct; 35(10):1725. PubMed ID: 33068472
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19: The heart of the issue.
    Woodward B; Kermali M
    J Card Surg; 2020 Aug; 35(8):2112. PubMed ID: 32542802
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
    Wu C; Ye D; Mullick AE; Li Z; Danser AHJ; Daugherty A; Lu HS
    Hypertension; 2020 Oct; 76(4):e29-e30. PubMed ID: 32673509
    [No Abstract]   [Full Text] [Related]  

  • 13. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2.
    Wang C; Wang S; Li D; Wei DQ; Zhao J; Wang J
    Gastroenterology; 2020 Sep; 159(3):1145-1147.e4. PubMed ID: 32437749
    [No Abstract]   [Full Text] [Related]  

  • 14. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease and the impact of COVID-19.
    Yoganathan A; Sajjad MS; Harky A
    J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
    [No Abstract]   [Full Text] [Related]  

  • 16. Could angiotensin-converting enzyme 1
    Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
    J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
    [No Abstract]   [Full Text] [Related]  

  • 17. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
    Su S; Jiang S
    Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059
    [No Abstract]   [Full Text] [Related]  

  • 18. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
    Tsioufis C; Dimitriadis K; Tousoulis D
    Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19.
    Steardo L; Steardo L; Zorec R; Verkhratsky A
    Acta Physiol (Oxf); 2020 Jul; 229(3):e13473. PubMed ID: 32223077
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.
    Ferrandi PJ; Alway SE; Mohamed JS
    J Appl Physiol (1985); 2020 Oct; 129(4):864-867. PubMed ID: 32673162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.